Fundraising Fox
Nula Therapeutics
St. Petersburg, US · Founded 2021 · Delaware corporation · 4 employees on LinkedIn · 2 known investors
Find your way into Nula Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
562 people can intro you to Chris
Ask Dr. Jens Eckstein to introduce you to Chris Shepard
You →Dr. · together at Thymofox →Chris
Sign up to find every way you can get introduced to Nula Therapeutics
- Your email: who you already know at Nula Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Nula Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
CS
Christopher ShepardChief Executive Officer, Board of Directors, Co-FounderChristopher Shepard is a liver pathologist and drug development specialist with expertise in metabolic disease and oncology who founded Nula Therapeutics, where he serves as Executive Officer and Director. He previously held positions at Apollo Ventures, MIT's Biological Engineering Group, and as a Principal Investigator for the Department of Defense's Breast Cancer Research Program.
JR
Jarod RutledgeNamed on SEC filing
Board
NR
Investors · 2
Korify Capitallisted by Korify Capital
How we know: Korify Capital's portfolio page · Not right? Tell us
Apollo Health VenturesreportedBerlin
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$7.4M disclosed across 1 round · 2026
▶$7.4MraisedMar 2026 · 7 investors · BiotechnologyRule 506(b)
▶$7.4MraisedMar 2026 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jarod RutledgeDirector
- Christopher ShepardExecutive Officer, Director
- Nils ReggeDirector
- Offering amount
- $7.4M
- Amount sold
- $7.4M
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Nula Therapeutics's investors?
- Nula Therapeutics's investors include Korify Capital, Apollo Health Ventures.
- How much funding has Nula Therapeutics raised?
- Nula Therapeutics has disclosed $7.4M raised across 1 round.
- Where is Nula Therapeutics headquartered?
- Nula Therapeutics is headquartered in St. Petersburg, US.